Crestchem

Has Crestchem declared dividend?

Crestchem Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of August 23, 2024. The dividend yield is 0.3%, and while the company has shown significant price appreciation over the years, the total returns vary across different periods.

Crestchem Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.3%.<BR><BR>Total Returns by Period:<BR>Over the 6-month period, Crestchem experienced a price return of -39.7%, with no dividend return, resulting in a total return of -39.7%.<BR><BR>In the 1-year period, the price return was 26.84%, with a dividend return of 0.37%, leading to a total return of 27.21%.<BR><BR>For the 2-year period, the price return was 84.46%, with a dividend return of 0.68%, resulting in a total return of 85.14%.<BR><BR>During the 3-year period, the price return was 243.46%, with a dividend return of 1.12%, culminating in a total return of 244.58%.<BR><BR>In the 4-year period, the price return was 328.42%, with a dividend return of 1.10%, leading to a total return of 329.52%.<BR><BR>Over the 5-year period, Crestchem saw a remarkable price return of 1450.48%, with a dividend return of 4.76%, resulting in a total return of 1455.24%.<BR><BR>Overall, Crestchem has declared a dividend while also showing varying total returns over different periods, with significant growth in price returns, particularly over the longer term. The dividend yield remains relatively low compared to the substantial price appreciation.

Who are the peers of the Crestchem?

Crestchem's peers include Pidilite Industries, SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast & Waud, Seya Industries, Yug Decor, and Vikram Aroma. Crestchem has good management risk and growth, with a 1-year return of 31.30%, while Himadri Special leads with 41.42% return, and Seya Industries has the lowest at -22.50%.

Peers: The peers of Crestchem are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Hardcast.& Waud, Seya Industries, Yug Decor, Vikram Aroma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, Pidilite Inds., and SRF, while Good management risk is found at Crestchem and Yug Decor. Average management risk is present at Himadri Special and Gujarat Fluoroch, and Below Average management risk is noted for Hardcast.& Waud, Seya Industries, and Vikram Aroma. Growth is Good at Crestchem and Himadri Special, Average at Pidilite Inds. and SRF, Below Average at Gujarat Fluoroch, Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, and the rest have varying ratings. Capital Structure is Excellent at Pidilite Inds. and Deepak Nitrite, Good at Gujarat Fluoroch, Himadri Special, Crestchem, and Vikram Aroma, and Below Average at Seya Industries.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Himadri Special at 41.42%, while the lowest is Seya Industries at -22.50%. Crestchem's 1-year return of 31.30% is higher than Seya Industries but lower than Himadri Special. Additionally, several peers, including Deepak Nitrite, Hardcast.& Waud, Seya Industries, and Vikram Aroma, have negative six-month returns.

What is the technical trend for Crestchem?

As of June 2, 2025, Crestchem's technical trend has shifted to bearish, supported by a weak weekly MACD, bearish Bollinger Bands, and significant recent declines of -9.24% over one week and -15.63% over one month, despite a contrasting bullish monthly KST.

As of 2 June 2025, the technical trend for Crestchem has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly MACD is bearish, and Bollinger Bands are also signaling bearish conditions. Daily moving averages confirm the bearish trend. While the monthly KST is bullish, it contrasts with the bearish signals from other indicators. The stock has seen significant declines recently, with a 1-week return of -9.24% and a 1-month return of -15.63%, further supporting the bearish outlook.

Who are in the management team of Crestchem?

As of March 2023, the management team of Crestchem includes Dipak N Patel (Chairman & Managing Director), Khyati Dipakkumar Vyas (CFO & Company Secretary), and several non-executive and independent directors: Rajesh I Mody, Binaben Parasbhai Patel, Nitin Shantilal Shah, and Manojkumar Babubhai Patel, along with Executive Director Nirmit Dipak Patel.

As of March 2023, the management team of Crestchem includes the following members:<BR><BR>1. Dipak N Patel - Chairman & Managing Director<BR>2. Rajesh I Mody - Non-Executive & Independent Director<BR>3. Binaben Parasbhai Patel - Non-Executive & Independent Director<BR>4. Nitin Shantilal Shah - Non-Executive & Independent Director<BR>5. Khyati Dipakkumar Vyas - CFO & Company Secretary<BR>6. Manojkumar Babubhai Patel - Independent Director<BR>7. Nirmit Dipak Patel - Executive Director<BR><BR>These individuals play key roles in the governance and management of the company.

What does Crestchem do?

Crestchem Ltd is a micro-cap company specializing in the processing, manufacturing, trading, and marketing of specialty chemical ingredients. As of March 2025, it reported net sales of 72 Cr and a net profit of 6 Cr.

Overview:<BR>Crestchem Ltd is engaged in the processing, manufacturing, trading, and marketing of specialty chemical ingredients, operating within the specialty chemicals industry and classified as a micro-cap company.<BR><BR>History:<BR>Crestchem Limited was incorporated in April 1991. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 72 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 6 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 50 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.30% <BR>Debt Equity: -0.10 <BR>Return on Equity: 36.50% <BR>Price to Book: 6.73 <BR><BR>Contact Details:<BR>Address: Sr No 550/1 Sub Plot No 12, Village-Indrad Taluka Kadi Mehsana Gujarat : 382715 <BR>Tel: 91-2764-278247/09409119484 <BR>Email: info@crestchemlimited.in/investor@c <BR>Website: http://www.crestchemlimited.in

Who are the top shareholders of the Crestchem?

The top shareholder of Crestchem is Mr. Dipak Narendraprasad Patel, with a 28.94% stake. Individual investors hold 66.63% of the shares, with no institutional holdings or pledged promoter shares.

The top shareholders of Crestchem include Mr. Dipak Narendraprasad Patel, who holds the highest promoter stake at 28.94%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 66.63% of the shareholding. There are no institutional holdings from mutual funds or foreign institutional investors, and there are no pledged promoter holdings.

How big is Crestchem?

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, with recent net sales of 25.08 Cr and a net profit of 2.73 Cr. The balance sheet for March 2024 shows shareholder's funds of 4.90 Cr and total assets of 7.13 Cr.

As of 24th July, Crestchem Ltd has a market capitalization of 49.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Crestchem reported Net Sales of 25.08 Cr and a Net Profit of 2.73 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 4.90 Cr and Total Assets of 7.13 Cr.

When is the next results date for Crestchem?

Crestchem is scheduled to declare its results on 12 November 2025.

Crestchem is scheduled to declare its results on 12 November 2025.

How has been the historical performance of Crestchem?

Crestchem has shown significant growth in net sales and profitability, with net sales increasing from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, and profit after tax rising from 0.57 Cr to 2.73 Cr during the same period. The company's financial performance reflects strong operational efficiency and enhanced shareholder value.

Answer:<BR>The historical performance of Crestchem shows a significant upward trend in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Crestchem's net sales have increased from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising from 7.64 Cr in Mar'21 to 25.08 Cr in Mar'25. The raw material costs also increased, from 5.82 Cr in Mar'21 to 18.76 Cr in Mar'25, indicating higher production expenses. Operating profit, excluding other income, improved from 0.65 Cr in Mar'21 to 3.28 Cr in Mar'25, while the overall operating profit rose from 0.70 Cr to 3.72 Cr during the same period. Profit before tax showed a notable increase from 0.67 Cr in Mar'21 to 3.66 Cr in Mar'25, leading to a profit after tax of 2.73 Cr in Mar'25, up from 0.57 Cr in Mar'21. The earnings per share also grew significantly from 1.9 in Mar'21 to 9.1 in Mar'25. On the balance sheet, total assets increased from 3.00 Cr in Mar'21 to 10.52 Cr in Mar'25, while total liabilities rose from 3.00 Cr to 10.52 Cr, with no long-term borrowings reported. The book value per share improved from 4.97 in Mar'21 to 24.92 in Mar'25, indicating enhanced shareholder value. Cash flow from operating activities turned positive in Mar'24 at 1.00 Cr and remained steady in Mar'25, showcasing improved operational efficiency. Overall, Crestchem's financial performance demonstrates robust growth and profitability over the years.

Is Crestchem overvalued or undervalued?

As of November 19, 2025, Crestchem is fairly valued with a PE ratio of 17.38 and has underperformed the Sensex with a year-to-date return of -58.22%, making it less attractive compared to peers like Godrej Industries and Solar Industries.

As of 19 November 2025, Crestchem's valuation grade has moved from very attractive to fair, indicating a shift in its market perception. The company is currently fairly valued, with a PE ratio of 17.38, an EV to EBITDA of 15.34, and a ROE of 25.03%. In comparison, peers such as Godrej Industries, which is rated attractive, has a significantly higher PE ratio of 37.28, while Solar Industries is deemed very expensive with a PE of 94.38.<BR><BR>Despite the fair valuation, Crestchem has underperformed relative to the Sensex, with a year-to-date return of -58.22% compared to the Sensex's 9.02%. This underperformance, coupled with its current ratios, suggests that while Crestchem may not be undervalued, it is not positioned as a strong investment compared to its peers in the specialty chemicals sector.

Are Crestchem Ltd latest results good or bad?

Crestchem Ltd's latest results show strong revenue and profit growth, with a net profit increase of 33.33% quarter-on-quarter. However, concerns about declining operating margins and bearish market trends suggest caution for investors.

Crestchem Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹0.72 crore for Q3 FY26, which is a significant increase of 33.33% quarter-on-quarter and 38.46% year-on-year. Additionally, revenue saw a substantial year-on-year growth of 49.17%, reaching ₹7.16 crore, although it experienced a slight decline of 0.42% compared to the previous quarter.<BR><BR>However, there are notable concerns regarding the company's operating margins, which have compressed significantly. The operating margin, excluding other income, fell to 11.31%, down from 13.54% in the same quarter last year, indicating rising cost pressures in the specialty chemicals sector. This margin compression raises questions about the sustainability of profit growth, as the increase in profits seems to be driven more by revenue expansion rather than operational efficiency.<BR><BR>Furthermore, the company's return on equity remains strong at 32.76%, reflecting effective capital utilization, but the overall financial performance is tempered by the bearish technical trends and a proprietary score that places it in "Strong Sell" territory.<BR><BR>In summary, while Crestchem has shown impressive revenue and profit growth, the deterioration in operating margins and the broader market performance suggest caution. Investors should closely monitor future results to assess whether the company can stabilize its margins and maintain its growth trajectory.

Should I buy, sell or hold Crestchem Ltd?

Which are the latest news on Crestchem?

Why is Crestchem Ltd falling/rising?

As of 26-Mar, Crestchem Ltd's stock price is rising to Rs 92.54, reflecting a 3.35% increase and outperforming its sector. This marks a trend reversal after two days of decline, with increased investor participation suggesting a potential recovery phase.

As of 26-Mar, Crestchem Ltd's stock price is rising, currently at Rs 92.54, reflecting a change of 3.0 (3.35%) upward. This increase is notable as the stock has outperformed its sector by 1.65% today. Additionally, the stock opened with a gain of 3.35%, indicating strong initial investor interest. <BR><BR>Today's performance marks a trend reversal, as the stock has gained after two consecutive days of decline. The stock also reached an intraday high of Rs 92.54, which aligns with the positive momentum observed in today's trading. Furthermore, there has been a rise in investor participation, with delivery volume increasing by 12.89% compared to the 5-day average, suggesting heightened interest from investors.<BR><BR>While the stock has experienced a significant decline over the past year, with a drop of 57.83%, the recent performance indicates a potential recovery phase, especially in light of its current outperformance against the benchmark Sensex, which has seen a decline of 1.87% over the past week. Overall, the combination of a positive opening, increased trading volume, and a reversal from previous declines contributes to the current rise in Crestchem Ltd's stock price.

Why is Crestchem Ltd falling/rising?

As of 27-Mar, Crestchem Ltd's stock price is at 83.51, reflecting a decline of 7.25%. The stock has underperformed significantly, with a year-to-date decrease of 25.74% and is trading below all major moving averages, indicating a bearish trend amidst challenging market conditions.

As of 27-Mar, Crestchem Ltd's stock price is falling, currently at 83.51, which reflects a decrease of 6.53 or 7.25%. This decline is evident in the stock's performance over various periods, including a 1-week drop of 8.07% and a year-to-date decrease of 25.74%. The stock has also significantly underperformed compared to the Sensex, which has only declined by 1.27% over the past week.<BR><BR>Today's trading session has been particularly challenging for Crestchem, as it opened with a loss of 2.25% and reached an intraday low of Rs 80, marking an 11.15% drop at its lowest point. The stock has shown high volatility, with an intraday volatility of 5.87%, indicating significant price fluctuations throughout the day. Additionally, Crestchem is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further suggesting a bearish trend.<BR><BR>The chemicals sector as a whole has also experienced a decline, falling by 2.29%, which may contribute to the negative sentiment surrounding Crestchem. Despite a rise in delivery volume by 37.13% on March 25, indicating increased investor participation, the overall market conditions and the stock's performance relative to benchmarks suggest that Crestchem Ltd is currently facing downward pressure.

Why is Crestchem Ltd falling/rising?

As of 28-Mar, Crestchem Ltd's stock price is falling at 83.51, down -7.25%. The stock has significantly underperformed the market, with a year-to-date drop of -25.74% and a yearly decline of -60.38%, leading to strong sell sentiment.

As of 28-Mar, Crestchem Ltd's stock price is falling, currently at 83.51, reflecting a change of -6.53 (-7.25%). The stock has underperformed significantly compared to the broader market, with a 1-week decline of -8.07% and a year-to-date drop of -25.74%. Over the past year, the stock has plummeted by -60.38%, while the Sensex has only decreased by -5.18% during the same period.<BR><BR>Today's trading activity shows that the stock opened down by -2.25% and reached an intraday low of Rs 80, marking a decline of -11.15%. The stock has exhibited high volatility, with an intraday volatility of 5.87%. Additionally, it is trading below all its moving averages, indicating a bearish trend.<BR><BR>The chemicals sector, in which Crestchem operates, has also seen a decline of -2.29%, contributing to the negative sentiment surrounding the stock. Despite some positive factors such as high management efficiency and a low debt-to-equity ratio, the overall performance remains below par, with flat results reported in December and a significant drop in profits by -20.1% over the past year. This combination of factors has led to a strong sell sentiment for Crestchem Ltd.

Why is Crestchem Ltd falling/rising?

As of 29-Mar, Crestchem Ltd's stock price is at 83.51, reflecting a significant decline of -60.38% over the past year and underperformance compared to the broader market. The stock is currently classified as a strong sell due to its bearish trend and poor financial results.

As of 29-Mar, Crestchem Ltd's stock price is falling, currently at 83.51, which reflects a change of -6.53 or -7.25%. The stock has underperformed significantly in various time frames, with a year-to-date decline of -25.74% compared to the Sensex's -13.66%. Over the past year, the stock has plummeted by -60.38%, while the broader market has only seen a -5.18% decline.<BR><BR>Today's performance indicates a particularly challenging situation, as the stock opened down by -2.25% and reached an intraday low of Rs 80, marking a decrease of -11.15%. The stock has also been highly volatile, with an intraday volatility of 5.87%. Furthermore, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend.<BR><BR>The chemicals sector itself has fallen by -2.29%, contributing to the negative sentiment surrounding Crestchem. Despite some positive factors, such as high management efficiency and a low debt-to-equity ratio, the company's flat results and significant profit decline of -20.1% over the past year have overshadowed these strengths. The stock's performance has been below par both in the near term and long term, leading to its classification as a strong sell.